The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn's Disease

Dotan Yogev; Bram Verstockt; Axel Dignass; Gili Focht; Ohad Atia; Iris Dotan; Severine Vermeire; Dan Turner

doi:10.1093/ibd/izac235

The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn's Disease

Inflamm Bowel Dis. 2023 Jul 5;29(7):1170-1174. doi: 10.1093/ibd/izac235.

Authors

Dotan Yogev^{1

2}, Bram Verstockt^{3

4}, Axel Dignass⁵, Gili Focht^{1

2}, Ohad Atia², Iris Dotan^{6

7}, Severine Vermeire^{3

4}, Dan Turner^{1

2}

Affiliations

¹ Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, Jerusalem, Israel.
² Hebrew University of Jerusalem, Jerusalem, Israel.
³ Department of Gastroenterology and Hepatology, University Hospital Leuven, KU Leuven, Leuven, Belgium.
⁴ Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
⁵ Department of Medicine I, Agaplesion Markus Hospital, Frankfurt, Germany.
⁶ Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
⁷ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

PMID: 36350981
DOI: 10.1093/ibd/izac235

No abstract available

Plain language summary

The Mucosal Inflammation Noninvasive Index is a validated noninvasive tool to assess endoscopic remission in pediatric Crohn’s disease. In this study, we evaluated a modified version of the Mucosal Inflammation Noninvasive Index on adult cohorts to explore its validly in adult Crohn’s disease.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Crohn Disease*
Endoscopy
Humans
Inflammation
Remission Induction
Severity of Illness Index